These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 20516049)

  • 1. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon.
    Kuaban C; Bame R; Mouangue L; Djella S; Yomgni C
    East Afr Med J; 2009 May; 86(5):219-25. PubMed ID: 20084990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
    Long R; Bochar K; Chomyc S; Talbot J; Barrie J; Kunimoto D; Tilley P
    Infect Control Hosp Epidemiol; 2003 Nov; 24(11):831-8. PubMed ID: 14649771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY; Chen YT; Shu CC; Lee JJ; Wang JY; Yu CJ; Yang PC
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D; Radenbach D; Magnussen H
    Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
    Harries AD; Gausi F; Chimzizi R; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment.
    Kim TC; Blackman RS; Heatwole KM; Kim T; Rochester DF
    Am Rev Respir Dis; 1984 Feb; 129(2):264-8. PubMed ID: 6421211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.
    Rockwood N; Pasipanodya JG; Denti P; Sirgel F; Lesosky M; Gumbo T; Meintjes G; McIlleron H; Wilkinson RJ
    Clin Infect Dis; 2017 May; 64(10):1350-1359. PubMed ID: 28205671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis.
    van der Kuyp F; Mahan CS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1663-7. PubMed ID: 23131266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.
    Moraes ML; Ramalho DM; Delogo KN; Miranda PF; Mesquita ED; de Melo Guedes de Oliveira HM; Netto AR; Dos Anjos MJ; Kritski AL; de Oliveira MM
    Biol Trace Elem Res; 2014 Aug; 160(2):176-84. PubMed ID: 24958018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
    Suárez-Méndez R; García-García I; Fernández-Olivera N; Valdés-Quintana M; Milanés-Virelles MT; Carbonell D; Machado-Molina D; Valenzuela-Silva CM; López-Saura PA
    BMC Infect Dis; 2004 Oct; 4():44. PubMed ID: 15500691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.